Bruker (FRA:BKD) Other Current Liabilities: €517 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:BKD Bruker Corp FRA:BKD
86 GF Score
Price €51.50
GF Value €55.57
Valuation Fairly Valued
! 10 Warning Signs
View Full Analysis

What is Bruker Other Current Liabilities?

Bruker FRA:BKD +1.36% 86 Other Current Liabilities is €517 Mil as of Mar. 2026. GuruFocus rates FRA:BKD with a GF Score™ of 86/100 and a GF Value™ of €55.57 (Fairly Valued). The stock has 10 warning signs investors should review.

Bruker's other current liabilities for the quarter that ended in Mar. 2026 was €517 Mil.

Bruker's quarterly other current liabilities declined from Sep. 2025 (€515 Mil) to Dec. 2025 (€294 Mil) but then increased from Dec. 2025 (€294 Mil) to Mar. 2026 (€517 Mil).

Bruker's annual other current liabilities increased from Dec. 2023 (€200 Mil) to Dec. 2024 (€211 Mil) and increased from Dec. 2024 (€211 Mil) to Dec. 2025 (€294 Mil).

Bruker Other Current Liabilities Related Terms

Bruker Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Bruker's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bruker Other Current Liabilities Chart

Bruker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 138.41 150.95 200.18 211.25 294.46

Bruker Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 547.60 494.71 514.61 294.46 517.18
FRA:BKD
86GF Score
Bruker Corp FRA:BKD
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bruker Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of €517 Mil mean?
Bruker (FRA:BKD) has a Other Current Liabilities of €517 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bruker.
Is Bruker's Other Current Liabilities too high?
Bruker's current Other Current Liabilities is €517 Mil. Overall, Bruker has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Bruker's Other Current Liabilities compare to GKOS and BIO?
Bruker's Other Current Liabilities of €517 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Bruker. Bruker's current Other Current Liabilities is €517 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bruker stock overvalued right now?
Based on GuruFocus' analysis, Bruker (FRA:BKD) is currently considered Fairly Valued. The stock's GF Value™ is €55.57, compared to a current price of €51.50 — trading 7.3% below its estimated fair value. The current Other Current Liabilities is €517 Mil. Bruker's overall GF Score™ is 86/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Bruker (FRA:BKD), the current Other Current Liabilities is €517 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Bruker (FRA:BKD) Overvalued in 2026?

Based on GuruFocus' analysis, Bruker stock appears to be undervalued. The current stock price of €51.50 is trading 7.3% below its estimated GF Value™ of €55.57. GuruFocus considers Bruker to be Fairly Valued.

Key valuation signals for FRA:BKD:

  • Other Current Liabilities: €517 Mil
  • GF Value™: €55.57 vs. price of €51.50 (7.3% below fair value)
  • GF Score™: 86/100 with 10 warning signs

No single metric tells the full story. See the FRA:BKD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bruker Business Description

Address 40 Manning Road, Billerica, MA, USA, 01821
Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies (BEST) . The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.
86GF Score

Get the complete analysis for FRA:BKD

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€51.50
Price
€55.57
GF Value